| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
3,975 |
1,228 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
394 |
338 |
$4K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
214 |
122 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
592 |
579 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
667 |
604 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,509 |
1,571 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
326 |
310 |
$0.00 |
| 91301 |
|
59 |
59 |
$0.00 |
| 91306 |
|
23 |
23 |
$0.00 |
| 0012A |
|
33 |
33 |
$0.00 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
14 |
12 |
$0.00 |
| 0011A |
|
23 |
23 |
$0.00 |
| 0064A |
|
23 |
23 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16 |
16 |
$0.00 |
| 80061 |
Lipid panel |
312 |
307 |
$0.00 |
| 80164 |
|
56 |
53 |
$0.00 |
| G8990 |
Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals |
16 |
12 |
$0.00 |